Ceptyr, Inc was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored niche in pharmaceutical development.

Exelixis is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases. The majority of its programs focus on the discovery and development of small molecule drugs for cancer. The Company has a pipeline of compounds in various stages of development for the treatment of cancer and various metabolic, cardiovascular and inflammatory disorders. All of its development compounds were generated through its internal drug discovery activities, although it is developing certain of these compounds in collaboration with partners and has out-licensed to others. The Company is focusing its development activities on its clinical compounds, XL184, XL147 and XL765. XL184, the Company's advanced drug candidate, inhibits MET, VEGFR2 and RET, proteins that are key drivers of tumor growth and/or vascularization. XL147 is a selective inhibitor of PI3K while XL765 is a dual inhibitor of PI3K and mTOR.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Vectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively dedicated to providing lentiviral vectors, cell models, molecular biology strategies and supporting your projects. Vectalys aims to help scientists worldwide understand cellular and molecular mechanisms in order to discover new drugs and therapies. Vectalys has developed a state-of-the-art proprietary technology to provide the highest quality of lentiviral vectors for the transduction of hard-to-transfect cells like primary cells, stem cells and in vivo tissues. Vectalys high quality lentiviral vectors ensure 100% transduction efficiency and non-toxic transduction on any target cells, for example to create predictive models. Because each project is unique, the Vectalys team supports you by providing custom lentiviral vectors for the right application with your gene of interest. Vectalys is also the manufacturer of highly pure ready-to-use lentiviral vectors carrying fluorescent, bioluminescent or gene editing proteins. These products are distributed worldwide. Vectalys is committed to providing solutions that save your time and support your most ambitious projects.

Jiangxi Meiao Biotechnology Co., Ltd., established on 2017-05-19, Business scope includes biopharmaceutical research and development,Production,Sales;Research and development of bioengineering technology,Technical Services,technology transfer,technical consulting;stem cell storage;Development and Application of Stem Cell Technology;Research and development of medical supplies and equipment,Production,Sales;cosmetic,Production of hygiene products,processing,Sales;Self-operated or agent import and export business of various commodities and technologies;Nutrition and Health Consulting;Online Trade Agent.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

DaNAgreen Co. Ltd. is a South Korean company located in Seoul that develops low cost cell therapy technology. The firm was founded in 2016 by Gi-Woo Kim.

Zhongshan Ophthalmic Center, part of Sun Yat-Sen University, is a Chinese company located in Guangzhou that operates hospitals.

Develops non-implanted bioelectrical devices for clinical applications

ReInnervate Limited, a biotechnology company, engages in the development of enabling technologies that facilitate research into cell growth and function in vitro, primarily in the field of stem cell biology. Its technologies control the differentiation of stem cells and the formation of specific tissue types, as well as offers tools to develop diagnostics and treatments for neuro-degenerative diseases. The company was founded in 2002 and is based in Durham, the United Kingdom.

Acen Med is a biomedical research and advanced cell engineering firm. Their products include stem cell preparations, 3D printed stem cell products, stem cell extracts, immune cell preparations, serum-free medium, cell bioreactors, and cell storage.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Hisonic, Inc. designs and manufactures custom magnetic devices for both military and commercial applications. Its transformers, inductors, filters and magnetic assemblies are used in avionics, power supplies, satellites, missile guidance systems, radar, microwave, and data processing systems. The company was founded in 1959 and is headquartered in Olathe, KS.

Jiangsu gdk Biotechnology Co., Ltd. engages in the research and development, production, and sale of human vaccines. Its products include freeze-dried human rabies, quadrivalent influenza virus, 23-valent pneumococcal polysaccharide, freeze-dried live attenuated varicella, freeze-dried live attenuated herpes zoster, 13-valent pneumococcal polysaccharide conjugate, and recombinant shingles vaccines. The company was founded by Yun De Hou and Jing Zhao on December 29, 2008 and is headquartered in Taizhou, China.

Shangpu (Beijing) Biotechnology Co., Ltd., established on 2018-09-13, Business scope includes biotechnology development,technical consulting,technology transfer,Technical Services;3DPrinting technology development,Serve,transfer,consult;Manufacture of computer peripherals;Additive Manufacturing Equipment Manufacturing;Manufacturing of bio-based materials;Rental Additive Manufacturing Equipment;Sales of bio-based materials,3Dprinter,Equipment,Computer software and auxiliary equipment,Additive Manufacturing Equipment,electronic product,Instrumentation,computer,Software and Auxiliary Equipment,chemical synthesis material,biologics,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals);Import and export,Technology Import and Export,Agent import and export;engineering design;software development;product design;3Dprint service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Zicheng Ruishenghui (Beijing) Biotechnology Development Co., Ltd., established on 2015-03-25, Business scope includes biotechnology,biomedicine,Technology development of cell therapy technology,technology transfer,technical consulting,Technical Services;Technical testing;Medical Research and Experimental Development;sell plastic products,Glass product,Chemical Products,chemical reagent,Ι class medical device,cosmetic,daily necessities,Equipment,Electrical Equipment;Import and export,Technology Import and Export,Agent import and export;health management,Health Advisory(Except for medical treatment activities subject to approval);Economic Information Consulting;Conference Services;Medical Device Repair,lease;data processing(Bank Card Center in Data Processing,PUEvalue in1.5Except for the above cloud computing data centers);sell food.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Shanghai Kinetic Medical Co., Ltd. engages in the research and development, manufacture. and sale of orthopedic implants. Its business scopes include minimally invasive vertebroplasty, trauma or spine orthopedic implants, low temperature radiofrequency, medical device trading, and medical disinfection service businesses. Its Minimally Invasive Vertebroplasty business offers clinical minimally invasive surgical treatment of vertebral body compression fractures caused by osteoporosis. Its Trauma or Spine Orthopedic Implants business provides hip prosthesis, bone cement, titanium mesh, spinal fixation, interlocking intramedullary nails, and anatomical bone plates. Its Low Temperature Radiofrequency business offers surgical energy platforms and consumables. Its Medical Device Trading operates a medical device distribution service platform. Its Medical Disinfection Service business is involved in the provision of medical services for hospitals, health service centers, and outpatient clinics. The company was founded on March 31, 2005 and is headquartered in Shanghai, China.